Covid-19 Treatment Developer AbCellera Biologics Files for IPO

(Bloomberg) -- Canadian antibody-drug discovery platform AbCellera Biologics Inc. filed for an initial public offering, detailing plans for an antibody treatment for Covid-19 that it’s developing w...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.